Dr Xing Xu | Centre for Misfolding Diseases

skip to content

Research Associate

Publications

Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.

X Xu, Y Wang, NS Bryce, K Tang, NS Meagher, EY Kang, LE Kelemen, M Köbel, SJ Ramus, M Friedlander, CE Ford, EC Hardeman, PW Gunning

– British journal of cancer

(2021)

125,

265

(doi: 10.1038/s41416-021-01420-y)